Utilizing human cerebral organoids to model breast cancer brain metastasis in culture

• Published in: Breast cancer research : BCR Vol. 26; no. 1; pp. 108 - 16
• Main Authors: Wang, Chenran, Nagayach, Aarti, Patel, Harsh, Dao, Lan, Zhu, Hui, Wasylishen, Amanda R, Fan, Yanbo, Kendler, Ady, Guo, Ziyuan
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 01.07.2024; BioMed Central; BMC
• Subjects: Brain - pathology; Brain cancer; Brain metastasis; Brain Neoplasms - pathology; Brain Neoplasms - secondary; Brain slice preparation; Brain tumors; Breast cancer; Breast Neoplasms - pathology; Cancer; Care and treatment; Cell Communication; Cell culture; Cell interactions; Cell Line, Tumor; Cell-cell communication; Cerebral organoids; Coculture Techniques; Communication; Embryo cells; Embryogenesis; Embryonic stem cells; Female; Glioma; Humans; Lethality; Metastases; Metastasis; Neural cells; Oncology, Experimental; Organoids; Organoids - pathology; Proteins; Scientific equipment and supplies industry; Stem cells; Tumor cell lines; Tumor cells; Tumor microenvironment; Tumors; United States; Breast cancer; Tumor microenvironment; Neural cells; Brain metastasis; Cerebral organoids; Cell-cell communication
• ISSN: 1465-542X; 1465-5411; 1465-542X
• DOI: 10.1186/s13058-024-01865-y

Metastasis, the spread, and growth of malignant cells at secondary sites within a patient's body, accounts for over 90% of cancer-related mortality. Breast cancer is the most common tumor type diagnosed and the leading cause of cancer lethality in women in the United States. It is estimated that 10-16% breast cancer patients will have brain metastasis. Current therapies to treat patients with breast cancer brain metastasis (BCBM) remain palliative. This is largely due to our limited understanding of the fundamental molecular and cellular mechanisms through which BCBM progresses, which represents a critical barrier for the development of efficient therapies for affected breast cancer patients. Previous research in BCBM relied on co-culture assays of tumor cells with rodent neural cells or rodent brain slice ex vivo. Given the need to overcome the obstacle for human-relevant host to study cell-cell communication in BCBM, we generated human embryonic stem cell-derived cerebral organoids to co-culture with human breast cancer cell lines. We used MDA-MB-231 and its brain metastatic derivate MDA-MB-231 Br-EGFP, other cell lines of MCF-7, HCC-1806, and SUM159PT. We leveraged this novel 3D co-culture platform to investigate the crosstalk of human breast cancer cells with neural cells in cerebral organoid. We found that MDA-MB-231 and SUM159PT breast cancer cells formed tumor colonies in human cerebral organoids. Moreover, MDA-MB-231 Br-EGFP cells showed increased capacity to invade and expand in human cerebral organoids. Our co-culture model has demonstrated a remarkable capacity to discern the brain metastatic ability of human breast cancer cells in cerebral organoids. The generation of BCBM-like structures in organoid will facilitate the study of human tumor microenvironment in culture.